A Mutation Pentad Defined Outcome of De Novo and Cytogenetically Normal Acute Myeloid Leukaemia in Young Adults

被引：0
|
作者：
Tsui, Sze Pui [1 ]
Alvin, Ip H. W. [1 ]
Zhang, Chunxiao [2 ]
Tang, Tommy W. F. [3 ]
Lin, C. H. [4 ]
Cheung, Arthur [4 ]
Cheng, Grace [4 ]
So, Jason Chi Chiu [5 ]
Leung, S. Y. [5 ]
Au, Tommy C. H. [6 ]
Ma, Edmond S. K. [7 ]
Chan, Chris T. L. [7 ]
Ng, Margaret [8 ]
Cheng, Kelvin C. K. [8 ]
Wong, Kit Fai [9 ]
Siu, Lisa L. P. [9 ]
Yip, Sze Fai [10 ]
Lin, S. Y. [11 ]
Lau, Szeman June [12 ]
Luk, T. H. [12 ]
Lee, Harold K. K. [13 ]
Lau, Chi Kuen [14 ]
Kho, Bonnie [15 ]
Kwong, Yok Lam [2 ,16 ]
Javed, Asif
Leung, Anskar Yu Hung [17 ]
机构：
[1] Queen Mary Hosp, Dept Pathol, Hong Kong, Peoples R China
[2] Univ Hong Kong, LKS Fac Med, Dept Med, Div Haematol Med Oncol & Haematopoiet Stem Cell T, Hong Kong, Peoples R China
[3] Queen Mary Hosp, Div Haematol, Dept Pathol, Hong Kong, Peoples R China
[4] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Peoples R China
[5] Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China
[6] Hong Kong Sanat & Hosp, Hong Kong, Peoples R China
[7] Hong Kong Sanat & Hosp, Dept Pathol, Hong Kong, Peoples R China
[8] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China
[9] Queen Elizabeth Hosp, Dept Pathol, Hong Kong, Peoples R China
[10] Tuen Mun Hosp, Dept Med, Hong Kong, Peoples R China
[11] United Christian Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China
[12] Queen Elizabeth Hosp, Dept Med, Hong Kong, Peoples R China
[13] Princess Margaret Hosp, Dept Med, Hong Kong, Peoples R China
[14] Tseung Kwan O Hosp, Dept Med, Hong Kong, Peoples R China
[15] Pamela Youde Nethersole Eastern Hosp, Dept Med, Hong Kong, Peoples R China
[16] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China
[17] Univ Hong Kong, Dept Med, Hong Kong, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-130810
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1400
引用
收藏
页数：4
相关论文
共 50 条
  • [41] The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia
    Chen, Xian
    Tian, Chuchu
    Hao, Zhuanghui
    Pan, Lingang
    Hong, Minglin
    Wei, Wei
    Muyey, Daniel Muteb
    Wang, Hongwei
    Chen, Xiuhua
    CANCER MEDICINE, 2023, 12 (09): : 10340 - 10350
  • [42] Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia
    Schwind, Sebastian
    Marcucci, Guido
    Kohlschmidt, Jessica
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Maharry, Kati
    Becker, Heiko
    Metzeler, Klaus H.
    Whitman, Susan P.
    Wu, Yue-Zhong
    Powell, Bayard L.
    Baer, Maria R.
    Kolitz, Jonathan E.
    Carroll, Andrew J.
    Larson, Richard A.
    Caligiuri, Michael A.
    Bloomfield, Clara D.
    BLOOD, 2011, 118 (15) : 4188 - 4198
  • [43] RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis
    Lee, Seung-Shin
    Ahn, Jae-Sook
    Kim, Taehyung
    Kim, Hyeoung Joon
    Kim, Yeo-Kyeoung
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Park, Hee Jung
    Choi, Seung Hyun
    Jung, Chul Won
    Jang, Jun-Ho
    Kim, Heeje
    Moon, Joon Ho
    Sohn, Sang Kyun
    Won, Jong-Ho
    Kim, Sung-Hyun
    Zhang, Zhaolei
    Kim, Dennis Dong Hwan
    BLOOD, 2016, 128 (22)
  • [44] TET2 MUTATIONS OCCUR IN OVER 20% OF ADULTS WITH DE NOVO CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKEMIA, AND THEIR PREVALENCE INCREASES WITH AGE: A CANCER AND LEUKEMIA GROUP B STUDY
    Metzeler, K.
    Maharry, K.
    Margeson, D.
    Curfman, J.
    Becker, H.
    Radmacher, M.
    Mrozek, K.
    Holland, K.
    Whitman, S.
    Wu, Y.
    Schwind, S.
    Blum, W.
    Powell, B.
    Carter, T.
    Baer, M.
    Carroll, A.
    Kolitz, J.
    Caligiuri, M.
    Larson, R.
    Marcucci, G.
    Bloomfield, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 12 - 13
  • [45] CEBPA germline mutation screening in cytogenetically normal acute myeloid leukemia with somatically acquired CEBPA mutations
    Corbacioglu, Andrea
    Frohling, Stefan
    Mendla, Corinna
    Eiwen, Karina
    Habdank, Marianne
    Dohner, Hartmut
    Schlenk, Richard F.
    Dohner, Konstanze
    BLOOD, 2007, 110 (11) : 114A - 114A
  • [46] Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia
    Wen-Chi Yang
    Wan-Chi Tsai
    Pai-Mei Lin
    Ming-Yu Yang
    Yi-Chang Liu
    Chao-Sung Chang
    Wen-Hui Yu
    Sheng-Fung Lin
    Journal of Biomedical Science, 20
  • [47] Improving the molecular risk classification for younger (<60 years) de novo cytogenetically normal acute myeloid leukemia (CN AML) patients (pts)
    Marcucci, G.
    Maharry, K.
    Whitman, S. P.
    Paschka, P.
    Baldus, C. D.
    Langer, C.
    Mrozek, K.
    Kolitz, J. E.
    Larson, R. A.
    Bloomfield, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia
    Yang, Wen-Chi
    Tsai, Wan-Chi
    Lin, Pai-Mei
    Yang, Ming-Yu
    Liu, Yi-Chang
    Chang, Chao-Sung
    Yu, Wen-Hui
    Lin, Sheng-Fung
    JOURNAL OF BIOMEDICAL SCIENCE, 2013, 20
  • [49] The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes
    Olsson, Linda
    Zettermark, Sofia
    Biloglav, Andrea
    Castor, Anders
    Behrendtz, Mikael
    Forestier, Erik
    Paulsson, Kajsa
    Johansson, Bertil
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (02) : 292 - 301
  • [50] Mitochondrial cytochrome c oxidase subunit II variations predict adverse prognosis in cytogenetically normal acute myeloid leukaemia
    Silkjaer, Trine
    Nyvold, Charlotte Guldborg
    Juhl-Christensen, Caroline
    Hokland, Peter
    Norgaard, Jan Maxwell
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (04) : 295 - 303
12345